
The Results of the First Nine Months of the Universal Health Insurance System’s Operation Have Been Summarized
On November 17, a press conference was held at the Armenpress studio to summarize the results of the first nine months of operation of the Universal Health Insurance system. During the press conference, the key indicators for the third quarter of 2026, data on the utilization of medical services under the insurance package, the amounts of reimbursements made, and priorities for further expansion were presented.
The speakers at the press conference were Hayk Babayan, Acting Director General of the Universal Health Insurance Fund; Izabel Abgaryan, Director of Legal Affairs; and Tatyana Markaryan, Acting Director of Financial and Insurance Reimbursements.
The data presented indicate that insurance coverage expanded during this period. While the number of insured individuals stood at 1,574,219 in January 2026, it reached 1,818,771 by September. Thus, the number of insured individuals increased by 15.5% over the specified period, representing an increase of more than 244,000 people.
Alongside the growth in the number of insured individuals, the number of people utilizing medical services also increased. As of September, 1,020,527 individuals had utilized services included in the insurance package. Notably, during the first nine months of the system's operation, 56.1% of insured individuals had already utilized at least one medical service covered by the package. By comparison, this figure stood at 42.4% in June. This change demonstrates that the proportion of individuals actually utilizing their insurance coverage has increased over time.
Utilization of the medication program was also significant. Between January and September 2026, a total of 479,933 beneficiaries utilized the program. During the nine-month period, 4,101,823 instances of medication dispensing were recorded, 4,136,289 prescriptions were issued, and the total amount paid for medications reached approximately AMD 25 billion. An increase in medication expenditures was also recorded on a quarterly basis. Specifically, in the third quarter, from July to September, medication expenditures amounted to AMD 10.47 billion, representing a 13.7% increase compared to the second quarter and more than double the figure recorded in the first quarter.
Insurance reimbursements and financial results were also among the key topics discussed during the press conference. Between January and September 2026, the total amount of reimbursements made reached AMD 163.7 billion.
The press conference also addressed quality assurance and oversight of the medical services provided. It was noted that the Fund has multicomponent oversight mechanisms in place aimed at ensuring the quality of services delivered by contracted medical institutions. At the same time, queue automation mechanisms are being introduced to improve the efficiency of patient service processes.
At the conclusion of the press conference, media representatives had the opportunity to ask questions of the Fund's management and receive clarifications regarding the data presented and the planned changes.